Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Blood Advances|September 20, 2021
Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapySwetha Kambhampati Thiruvengadam, Ying Sheng, Chiung-Yu Huang, et al.American Journal of Clinical Oncology|April 24, 2018
Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic CollaborationJyoti Mayadev, Mohamed A Elshaikh, Alana Christie, et al.Transplantation and Cellular Therapy|July 25, 2025
Assessing Social Determinants of Health in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCTManuel R Espinoza-Gutarra, Jennifer Collins, Vanessa Kennedy, et al.Journal of Hematology & Oncology|June 14, 2017
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphomaNarendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, et al.CA: a Cancer Journal for Clinicians|January 20, 2016
Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialistStacy Tessler Lindau, Emily M Abramsohn, Shirley R Baron, et al.Frontiers in Oncology|July 30, 2019
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center ExperienceVipul Sheth, Vanessa Kennedy, Hugues de Lavallade, et al.British Journal of Haematology|February 17, 2022
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agentSandy On, Carolyn G Rath, Michelle Lan, et al.Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2019
MARS: Mutation-Adjusted Risk Score for Advanced Systemic MastocytosisMohamad Jawhar, Juliana Schwaab, Iván Álvarez-Twose, et al.Blood|July 5, 2024
A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemiaHrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz, et al.Pageof 3